We are live on
!
Find out more
KFC
Klingenstein Fields & Co Portfolio holdings
AUM
$2.86B
1-Year Est. Return
28.26%
This Fund
S&P 500
This Quarter
Est. Return
+3.3%
1 Year Est. Return
+28.26%
3 Year Est. Return
+93.38%
5 Year Est. Return
+106.8%
10 Year Est. Return
+364.29%
AUM
$2.14B
AUM Growth
+$140M
(+7%)
Cap. Flow
+$83.4M
Cap. Flow
% of AUM
3.9%
Top 10 Holdings %
Top 10 Hldgs %
40.56%
Holding
223
New
11
Increased
84
Reduced
50
Closed
12
Avg Time Held
10.1
quarters
Top 10 Avg Time Held
7.6
quarters
Top 20 Avg Time Held
8.2
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$21.5M |
| 2 |
Merck
MRK
|
+$15.8M |
| 3 |
Weyerhaeuser
WY
|
+$15M |
| 4 |
Broadcom
AVGO
|
+$12.9M |
| 5 |
FedEx
FDX
|
+$6.19M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$20M |
| 2 |
ABB
ABB Ltd
ABB
|
+$13.9M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.73M |
| 4 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$2.81M |
| 5 |
Anadarko Petroleum
APC
|
+$1.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 19.18% |
| 2 | Communication Services | 17.11% |
| 3 | Healthcare | 16.21% |
| 4 | Financials | 14.28% |
| 5 | Consumer Staples | 12.41% |
Similar funds
IA
SEGHC
CPCPP
HJGA
WGI
EMFAT
AF
ORCP
Klingenstein Fields & Co's Q2 2016 Portfolio in Review
As of Q2 2016, Klingenstein Fields & Co held 223 positions worth $2.14B, up 7% from $2B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Klingenstein Fields & Co deployed $83.4M of net new capital in Q2 2016, opening 11 new positions and adding to 84 existing holdings. Its largest new stake was Broadcom: 845,850 shares worth $13.1M.
By sector, the portfolio is most concentrated in Industrials at 19% of assets, down from 20% a quarter earlier, followed by Communication Services and Healthcare.
On the sell side, the largest reduction was AbbVie, an estimated $20M trimmed.
- Klingenstein Fields & Co's largest Q2 2016 buy was Broadcom: 845,850 shares worth $13.1M.
- Klingenstein Fields & Co added most to CVS Health in Q2 2016, an estimated $21.5M increase.
- Klingenstein Fields & Co's biggest Q2 2016 reduction was AbbVie, cutting an estimated $20M.
- Klingenstein Fields & Co fully exited ABB Ltd in Q2 2016, selling an estimated $13.9M.
- Klingenstein Fields & Co's ten largest holdings make up 41% of its $2.14B portfolio in Q2 2016.
- Klingenstein Fields & Co opened 11 new positions and closed 12 in Q2 2016.
- Klingenstein Fields & Co's portfolio value rose 7% quarter-over-quarter to $2.14B.
Based on Klingenstein Fields & Co's 13F filing for Q2 2016, filed 1 Aug 2016.